You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • FRI0396 Type2 Anti-CD20 Antibodies do not Rapidly Internalise from the Surface of B Cells from Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus and Lyse Them More Efficiently than Rituximab (Type 1 Anti-20Antibody)

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. SLE, Sjögren's and APS - treatment
FRI0396 Type2 Anti-CD20 Antibodies do not Rapidly Internalise from the Surface of B Cells from Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus and Lyse Them More Efficiently than Rituximab (Type 1 Anti-20Antibody)

 

Online download statistics by month:

Online download statistics by month: August 2014 to March 2024

AbstractFullPdf
Aug 2014100
Sep 2014200
Oct 2014200
Nov 2014700
Dec 2014200
Jan 2015200
Feb 2015200
Mar 2015501
Apr 2015300
Jun 2015501
Jul 2015200
Aug 20151601
Sep 2015800
Oct 2015500
Nov 2015300
Dec 2015400
Jan 2016701
Feb 2016600
Mar 2016600
Apr 2016700
May 2016300
Jun 2016801
Jul 2016500
Aug 2016300
Sep 2016300
Oct 2016400
Nov 2016600
Dec 2016400
Jan 2017800
Feb 2017400
Mar 2017800
Apr 2017500
May 2017300
Jun 2017300
Jul 2017200
Aug 2017800
Sep 2017600
Oct 20171200
Nov 2017600
Dec 2017800
Jan 2018800
Feb 2018200
Mar 2018600
Apr 2018600
May 20181400
Jun 2018400
Jul 20181000
Aug 20181400
Sep 20181000
Oct 2018801
Nov 2018400
Dec 2018200
Jan 2019200
Feb 2019400
Apr 2019400
May 2019200
Aug 2019202
Nov 20191400
Jul 2020200
Sep 20201001
Oct 2020400
Nov 2020400
Dec 2020200
Feb 2021200
Apr 2021201
Oct 2021200
Nov 2021400
Dec 2021600
Feb 2022200
Mar 2022200
Apr 2022400
May 2022400
Jul 20221200
Aug 2022800
Sep 2022200
Oct 2022200
Nov 2022400
Dec 20221000
Jan 2023200
Feb 2023400
Mar 2023200
May 2023200
Jun 2023100
Jul 2023400
Sep 20231001
Dec 20231000
Mar 2024200
Total445011